IOL Chemicals & Pharmaceuticals Ltd. (IN:IOLCP)
:IOLCP
Want to see IN:IOLCP full AI Analyst Report?
IOLCP Stock Chart & Stats
₹84.09
-₹4.90(-1.13%)
At close: 4:00 PM EST
₹84.09
-₹4.90(-1.13%)
Day’s Range― - ―
52-Week Range₹67.14 - ₹139.85
Previous CloseN/A
Volume410.76K
Average Volume (3M)113.78K
Market Cap
₹39.41B
Enterprise Value₹37.23B
Total Cash (Recent Filing)₹1.79B
Total Debt (Recent Filing)₹1.59B
Price to Earnings (P/E)28.6
Beta1.64
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.97%
Share Statistics
EPS (TTM)3.95
Shares Outstanding293,527,500
10 Day Avg. Volume248,884
30 Day Avg. Volume113,785
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)1.19
Price to Sales (P/S)0.92
P/FCF Ratio55.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.7
Revenue Forecast (FY)₹26.48B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageA very low debt-to-equity (~0.08) and a materially larger equity base provide durable financial resilience. This capital structure lowers interest and refinancing risk, supports counter-cyclical spending on working capital and capex, and preserves flexibility to pursue growth or weather sector slowdowns.
Diversified Two-segment Business Model (APIs & Chemicals)Operating across APIs and specialty/industrial chemicals creates structural revenue diversification and different end-market exposures. This reduces single-market dependency, enables shared manufacturing assets and know-how, and smooths demand volatility across pharma and industrial cycles over the medium term.
Recent Revenue And EPS ImprovementA rebound in revenue in FY2026 and strong reported EPS growth indicate operational recovery and better utilization of assets. If sustained, improving top-line and earnings momentum can help rebuild margins and cash flow over the next several quarters, supporting reinvestment and shareholder returns.
Bears Say
Material Margin Compression Since FY2021Margins have contracted sharply from FY2021 peak levels, reflecting likely weaker pricing, mix shifts, or higher input costs. Sustained lower gross and net margins reduce cash generation per unit of revenue, constrain reinvestment capacity and long-term profitability, and indicate structural pressures on pricing power.
Volatile And Weak Free Cash Flow / Poor Cash ConversionInconsistent free cash flow and low operating cash conversion versus reported profits show limited surplus cash after investment. This weakens the firm's ability to self-fund capex, pay consistent dividends, reduce debt, or pursue M&A, making long-term strategic options more constrained and financing needs potentially higher.
Reduced Returns On Equity Vs. Prior PeakROE has declined substantially from earlier highs, signalling that the company now generates much less profit per unit of equity. This decline reflects weaker margins or capital intensity and implies lower long-term shareholder returns absent structural improvements in pricing, mix or operating efficiency.
IOL Chemicals & Pharmaceuticals Ltd. News
IOLCP FAQ
What was IOL Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
IOL Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹67.14 and its highest was ₹139.85 in the past 12 months.
What is IOL Chemicals & Pharmaceuticals Ltd.’s market cap?
IOL Chemicals & Pharmaceuticals Ltd.’s market cap is ₹39.41B.
When is IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 54 days.
How were IOL Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
IOL Chemicals & Pharmaceuticals Ltd. released its earnings results on May 20, 2026. The company reported ₹1.8 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.8.
Is IOL Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts IOL Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does IOL Chemicals & Pharmaceuticals Ltd. pay dividends?
IOL Chemicals & Pharmaceuticals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.97%. See more information on IOL Chemicals & Pharmaceuticals Ltd. dividends here
What is IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IOL Chemicals & Pharmaceuticals Ltd. have?
IOL Chemicals & Pharmaceuticals Ltd. has 293,527,500 shares outstanding.
What happened to IOL Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
IOL Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹1.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.466%.
Which hedge fund is a major shareholder of IOL Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:IOLCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IOL Chemicals & Pharmaceuticals Ltd.
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
Technical Analysis
Aarti Drugs Limited
―
Granules India Limited
―
Hikal Limited
―
Neuland Laboratories Ltd.
―
Solara Active Pharma Sciences Ltd.
―